Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.

Arsenic is a known carcinogen specifically linked to skin cancer occurrence in regions with highly contaminated drinking water or in individuals who took arsenic-containing medicines. Presently, it is unknown whether such effects occur at environmental levels found in the United States. To address this question, the authors used data collected on 587 basal cell and 284 squamous cell skin cancer cases and 524 controls interviewed as part of a case-control study conducted in New Hampshire between 1993 and 1996. Arsenic was determined in toenail clippings using instrumental neutron activation analysis. The odds ratios for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) were close to unity in all but the highest category. Among individuals with toenail arsenic concentrations above the 97th percentile, the adjusted odds ratios were 2.07 (95% confidence interval (CI): 0.92, 4.66) for SCC and 1.44 (95% CI: 0.74, 2.81) for BCC, compared with those with concentrations at or below the median. While the risks of SCC and BCC did not appear elevated at the toenail arsenic concentrations detected in most study subjects, the authors cannot exclude the possibility of a dose-related increase at the highest levels of exposure experienced in the New Hampshire population.

[1]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[2]  T. Tosteson,et al.  Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. , 2000, American journal of epidemiology.

[3]  M. Rahman,et al.  The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. , 1999, Environmental health perspectives.

[4]  M. Karagas,et al.  Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA , 1999, International journal of cancer.

[5]  M. Karagas,et al.  The study of human nails as an intake monitor for arsenic using neutron activation analysis , 1998 .

[6]  T. Tosteson,et al.  Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. , 1998, Environmental health perspectives.

[7]  Y. Hsueh,et al.  Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  Y. Hsueh,et al.  Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. , 1997, Mutation research.

[9]  M. Karagas,et al.  Toenail samples as an indicator of drinking water arsenic exposure. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  C. Hopenhayn-Rich,et al.  Bladder Cancer Mortality Associated with Arsenic in Drinking Water in Argentina , 1996, Epidemiology.

[11]  D. Chakraborti,et al.  Arsenic in groundwater in six districts of West Bengal, India , 1996, Environmental geochemistry and health.

[12]  W. Willett,et al.  Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. , 1995, American journal of epidemiology.

[13]  A H Smith,et al.  Case-control study of bladder cancer and arsenic in drinking water. , 1995, American journal of epidemiology.

[14]  H. Mukhtar.  Skin Cancer: Mechanisms and Human Relevance , 1994 .

[15]  C. Lynch,et al.  The driver's license list as a population-based sampling frame in Iowa. , 1994, American journal of public health.

[16]  W. Willett,et al.  Toenail trace element levels as biomarkers: reproducibility over a 6-year period. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  O. Wong,et al.  An ecologic study of skin cancer and environmental arsenic exposure , 1992, International archives of occupational and environmental health.

[18]  N. Altman.  An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression , 1992 .

[19]  A. Smith,et al.  Cancer risks from arsenic in drinking water. , 1992, Environmental health perspectives.

[20]  E S Fisher,et al.  Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. , 1990, American journal of public health.

[21]  T. Stukel,et al.  A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. , 1990, The New England journal of medicine.

[22]  A. Albores,et al.  Chronic Arsenic Poisoning in the North of Mexico , 1983, Human toxicology.

[23]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[24]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[25]  J. M. Harrington,et al.  A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. , 1978, American journal of epidemiology.

[26]  W. Morton,et al.  Skin cancer and water arsenic in lane county, Oregon , 1976, Cancer.

[27]  O. Miettinen,et al.  Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.

[28]  R. Jackson,et al.  Arsenic and cancer. , 1975, Canadian Medical Association journal.

[29]  J. Goldsmith,et al.  Evaluation of health implications of elevated arsenic in well water , 1972 .

[30]  F. Burbank,et al.  CORRELATIONS BETWEEN CARCINOGENIC TRACE METALS IN WATER SUPPLIES AND CANCER MORTALITY , 1972, Annals of the New York Academy of Sciences.

[31]  W. Tseng,et al.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. , 1968, Journal of the National Cancer Institute.

[32]  S. How,et al.  Arsenical cancer of skin: Histologic study with special reference to Bowen's disease , 1968, Cancer.

[33]  O. Neubauer.  Arsenical Cancer: A Review , 1947, British Journal of Cancer.

[34]  D. Chakraborti,et al.  Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world: the status report up to August, 1995 , 1997 .

[35]  R. Calderon,et al.  Arsenic : exposure and health effects , 1997 .

[36]  D. Chakraborti,et al.  ARSENIC IN GROUNDWATER IN SEVEN DISTRICTS OF WEST BENGAL, INDIA : THE BIGGEST ARSENIC CALAMITY IN THE WORLD , 1996 .

[37]  P. Gomez-Caminero,et al.  Arsenic and arsenic compounds. , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[38]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[39]  R. Zaldívar.  Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. , 1974, Beitrage zur Pathologie.